Clinical Outlook for Type-1 and FOXP3+ T Regulatory Cell-Based Therapy
Open Access
- 25 November 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6, 593
Abstract
T regulatory cells (Tregs) are subsets of T lymphocytes specialized in modulating antigen-specific immune responses in vivo. Hence, Tregs represent an ideal therapeutic tool to control detrimental immune reactions. Based on solid pre-clinical results, investigators started testing the safety and efficacy of Treg-based therapies in humans. Despite promising results, a number of issues remain to be solved. We will discuss the results obtained from clinical trials and the challenges and risks we are facing in the further development of Treg-based therapies.Keywords
Funding Information
- Fondazione Telethon (TGT11E02)
This publication has 84 references indexed in Scilit:
- Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cellsEuropean Journal of Immunology, 2011
- Adenosine and Prostaglandin E2 Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T CellsJournal of Biological Chemistry, 2010
- Expansion of Allospecific Regulatory T Cells After Anergized, Mismatched Bone Marrow TransplantationScience Translational Medicine, 2009
- GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3 + regulatory T cellsProceedings of the National Academy of Sciences, 2009
- Plasticity of CD4+ FoxP3+ T cellsCurrent Opinion in Immunology, 2009
- Identification and characterization of IL-10/IFN-γ–producing effector-like T cells with regulatory function in human bloodJournal of Experimental Medicine, 2009
- IL-17–producing human peripheral regulatory T cells retain suppressive functionBlood, 2009
- Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and PeripheryImmunity, 2008
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionJournal of Experimental Medicine, 2007
- Cyclic adenosine monophosphate is a key component of regulatory T cell–mediated suppressionJournal of Experimental Medicine, 2007